We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues More Product-Specific Bioequivalence Guidances
FDA Issues More Product-Specific Bioequivalence Guidances
January 2, 2013
The FDA has released 23 new draft guidances and revised draft product-specific guidances that detail its recommendations for bioequivalence studies to support ANDAs.